ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma

被引:2
|
作者
Wen, Min [1 ,2 ]
Zou, Zi-Zheng [1 ,2 ]
Luo, Tiao [3 ]
Li, Xuan [1 ]
Liu, Su-You [4 ]
Li, Ji-Jia [5 ,6 ,7 ]
Luo, Zhi-Yong [1 ]
机构
[1] Cent South Univ, Sch Life Sci, Xiangya Sch Med,Hunan Prov Key Lab Basic & Appl H, Hunan Key Lab Anim Models Human Dis,Dept Biochem, Changsha 410008, Peoples R China
[2] Yiyang Med Coll, Dept Biochem & Mol Biol, Yiyang 413000, Peoples R China
[3] Cent South Univ, Xiangya Stomatol Hosp, Xiangya Sch Stomatol, Hunan Key Lab Oral Hlth Res, Changsha 410008, Peoples R China
[4] Cent South Univ, Sch Pharmaceut Sci, Dept Med Chem, Changsha 410006, Peoples R China
[5] Cent South Univ, Xiangya Hosp, Ctr Stomatol, Changsha 410008, Peoples R China
[6] Cent South Univ, Xiangya Hosp, Res Ctr Oral & Maxillofacial Tumor, Changsha 410008, Peoples R China
[7] Cent South Univ, Inst Oral Canc & Precanc Les, Changsha 410008, Peoples R China
基金
中国国家自然科学基金;
关键词
breast cancer; ZLM-7; 14-3-3; sigma; MDM2; cell cycle; COMBRETASTATIN A-4; APOPTOSIS; P53; HYPERMETHYLATION; ANGIOGENESIS; PROTEINS; PATHWAY; ANALOGS; COMPLEX; ARREST;
D O I
10.3390/ph15070874
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Breast cancer is one of the most prevalent malignancies with poor prognosis. Inhibition of angiogenesis is becoming a valid and evident therapeutic strategy to treat cancer. Recent studies uncovered the antiangiogenic activity of ZLM-7 (a combretastain A-4 derivative), but the regulatory mechanism is unclear. ZLM-7 treatment was applied in estrogen receptor-positive cell MCF-7, triple-negative breast cancer cell MDA-MB-231 and xenograft models. Transfections were conducted to overexpress or knockdown targeted genes. The gene and protein expressions were measured by qPCR and Western blotting assay, respectively. Cell proliferation and apoptosis were evaluated using the CCK8 method, clone formation assay and flow cytometry. We found that ZLM-7 upregulated 14-3-3 sigma expression but downregulated MDM2 expression in breast cancer cells. ZLM-7 delayed cell proliferation, promoted apoptosis and blocked cell-cycle progression in human breast cancer cells in vitro, while those effects were abolished by 14-3-3 sigma knockdown; overexpression of 14-3-3 sigma reproduced the actions of ZLM-7 on the cell cycle, which could be reversed by MDM2 overexpression. In xenograft models, ZLM-7 treatment significantly inhibited tumor growth while the inhibition was attenuated when 14-3-3 sigma was silenced. Collectively, ZLM-7 could inhibit MDM2 via upregulating 14-3-3 sigma expression, thereby blocking the breast cancer progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] 14-3-3τ Promotes Breast Cancer Invasion and Metastasis by Inhibiting RhoGDIα (vol 34, pg 2635, 2014)
    Xiao, Yang
    Lin, Vivian Y.
    Ke, Shi
    Lin, Gregory E.
    Lin, Fang-Tsyr
    Lin, Weei-Chin
    MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (16) : 3180 - 3180
  • [22] MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport
    Zhang, Fan
    Throm, Stacy L.
    Murley, Laura L.
    Miller, Laura A.
    Zatechka, D. Steven, Jr.
    Guy, R. Kiplin
    Kennedy, Rachel
    Stewart, Clinton F.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (01) : 24 - 34
  • [23] Regulation of H9C2 cell hypertrophy by 14-3-3η via inhibiting glycolysis
    Wan, Sha
    Wang, Songhao
    Yang, Xianfei
    Cui, Yalan
    Guan, Heng
    Xiao, Wenping
    Liu, Fang
    PLOS ONE, 2024, 19 (07):
  • [24] Breast cancer metastasis driven by ErbB2 and 14-3-3ξ A division of labor
    Wang, Yingqun
    CELL ADHESION & MIGRATION, 2010, 4 (01) : 7 - 9
  • [25] Methylation of ESR1 and 14-3-3 sigma promoter in serum as possible biomarkers for screening and diagnosis for breast cancer
    Martinez-Galan, Joaquina
    Torres-Torres, Blanca
    Ramon Delgado, Juan
    CANCER RESEARCH, 2013, 73
  • [26] Correlation of epidermal growth factor receptor (EGFR), androgen receptor (AR) and 14-3-3 sigma expression in breast cancer
    Ji, Zhimin
    Yang, Lili
    Ruan, Qiurong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10419 - 10430
  • [27] 14-3-3σ和Mdm2蛋白在浸润性乳腺癌中的表达及意义
    刘廷
    齐凤杰
    赵树鹏
    姚萍
    广东医学, 2012, 33 (02) : 192 - 195
  • [28] 14-3-3ζ-mediated hypomethylation of c-myc oncogene by downregulation of Dnmts contributes to initiation and progression of breast cancer
    Xu, Jia
    Yu, Dihua
    CANCER RESEARCH, 2010, 70
  • [29] The 14-3-3σ Tumor Suppressor Has Multiple Functions in ErbB2-Induced Breast Cancer
    Hynes, Nancy E.
    Smirnova, Tatiana
    CANCER DISCOVERY, 2012, 2 (01) : 19 - 22
  • [30] 14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition
    Lu, Jing
    Guo, Hua
    Treekitkarnmongkol, Warapen
    Li, Ping
    Zhang, Jian
    Shi, Bin
    Ling, Chen
    Zhou, Xiaoyan
    Chen, Tongzhen
    Chiao, Paul J.
    Feng, Xinhua
    Seewaldt, Victoria L.
    Muller, William J.
    Sahin, Aysegul
    Hung, Mien-Chie
    Yu, Dihua
    CANCER CELL, 2009, 16 (03) : 195 - 207